You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pharmacokinetic-Moedeling

Showing 51 - 75 of 6,082
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Breast Cancer Trial in Shijiazhuang (Doxorubicin HCl liposome injection)

Completed
  • Advanced Breast Cancer
  • Doxorubicin hydrochloride liposome injection
  • Shijiazhuang, China
    The Fourth Hospital of Hebei Medical University
Oct 18, 2023

Malignant Tumor Trial (SHR2554 tablet dosing, Omeprazole tablet dosing)

Not yet recruiting
  • Malignant Tumor
  • SHR2554 tablet dosing
  • Omeprazole tablet dosing
  • (no location specified)
Oct 17, 2023

COVID-19 Respiratory Infection Trial in Changchun (GST-HG171/ritonavir, ritonavir)

Active, not recruiting
  • COVID-19 Respiratory Infection
  • Changchun, Jilin, China
    The first hospital of Jilin University
Oct 10, 2023

Healthy Subjects Trial in Cheongju-si (DW6013)

Completed
  • Healthy Subjects
  • Cheongju-si, Korea, Republic of
    Chungbuk National University Hospital
May 16, 2023

Healthy Subjects Trial in Cheongju-si (DW6013)

Completed
  • Healthy Subjects
  • Cheongju-si, Korea, Republic of
    Chungbuk National University Hospital
May 16, 2023

Melanoma Trial (GME751, Keytruda - EU, Keytruda - US)

Not yet recruiting
  • Melanoma
  • (no location specified)
Nov 22, 2023

Paracetamol in Overweight and Obese Children

Not yet recruiting
  • Overweight
  • Obesity
  • Titration of paracetamol and its metabolites - scheme1
  • Titration of paracetamol and its metabolites - scheme 2
  • Paris, France
    Robert Debré University Hospital
Nov 14, 2023

T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)

Completed
  • T2DM (Type 2 Diabetes Mellitus)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 1, 2023

Healthy Male Trial in Beijing (Envafolimab with new manufacturing process, Envafolimab with old manufacturing process)

Not yet recruiting
  • Healthy Male
  • Envafolimab with new manufacturing process
  • Envafolimab with old manufacturing process
  • Beijing, Beijing, China
    Beijing Gaobo Boren Hosipital
May 9, 2023

Advanced Solid Tumours Trial in Belgium, France (EXS21546)

Recruiting
  • Advanced Solid Tumours
  • Brussels, Belgium
  • +4 more
Jun 26, 2023

Solid Tumor Trial (Disitamab vedotin)

Not yet recruiting
  • Solid Tumor
  • Disitamab vedotin
  • (no location specified)
Jul 10, 2023

Healthy Trial in Iowa City (drug, diagnostic test, other)

Not yet recruiting
  • Healthy
  • Metronidazole 0.75% Topical Gel
  • +5 more
  • Iowa City, Iowa
    University of Iowa
Jun 29, 2023

Gastroesophageal Reflux Disease Trial (Vonoprazan)

Not yet recruiting
  • Gastroesophageal Reflux Disease
  • (no location specified)
Oct 24, 2023

Healthy Volunteers Trial in Saint Paul (Dupilumab (SAR231893))

Completed
  • Healthy Volunteers
  • Dupilumab (SAR231893)
  • Saint Paul, Minnesota
    Prism Research-Site Number:840001
Jul 28, 2023

Healthy Subjects Trial in Cheongju-si (DW6014)

Completed
  • Healthy Subjects
  • Cheongju-si, Korea, Republic of
    Chungbuk National University Hospital
Apr 10, 2023

DW6014 Trial in Cheongju-si (DW6014)

Not yet recruiting
  • DW6014
  • Cheongju-si, Korea, Republic of
    Chungbuk National University Hospital
Apr 10, 2023

Cancer Trial (AB801, Placebo)

Not yet recruiting
  • Cancer
  • (no location specified)
Aug 15, 2023

Cystic Fibrosis Trial in Tempe (Vanzacaftor, Vanzacaftor Placebo, Moxifloxacin)

Recruiting
  • Cystic Fibrosis
  • Tempe, Arizona
    Celerion - Tempe
May 16, 2023

Pharmacokinetics Trial in Seoul (IY-NT-T, IY-NT-R)

Recruiting
  • Pharmacokinetics
  • Seoul, Gwanak-gu, Korea, Republic of
    H plus Yangji Hospital
Nov 8, 2022

Cadmium Exposure Trial in Changsha (GMDTC for injection, Normal saline)

Recruiting
  • Cadmium Exposure
  • GMDTC for injection
  • Normal saline
  • Changsha, Hunan, China
    Hunan Occupational Disease Prevention and Control Institute
Jun 9, 2023

Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)

Not yet recruiting
  • Melanoma
  • ABP 206
  • +2 more
  • (no location specified)
Jun 8, 2023

Rheumatoid Arthritis Trial in China (Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection)

Completed
  • Rheumatoid Arthritis
  • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection
  • Beijing, Beijing, China
  • +14 more
Jul 21, 2023

Asthma Trial in Sichuan (HBM9378 (SKB378) Injection, Placebo)

Recruiting
  • Asthma
  • HBM9378 (SKB378) Injection
  • Placebo
  • Sichuan, Chengdu, China
    The Fifth People's Hospital of Chengdu
Mar 16, 2023

Healthy Trial in Shanghai (CS12192 capsule, Placebo capsule)

Not yet recruiting
  • Healthy
  • CS12192 capsule
  • Placebo capsule
  • Shanghai, Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Jun 27, 2023

Asthma, Genotype Trial in Indianapolis (Slow Release DHEA)

Recruiting
  • Asthma
  • Genotype
  • Slow Release DHEA
  • Indianapolis, Indiana
  • +1 more
Jan 19, 2023